- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04324970
Does the "TOOKIE Vest" Reduce Line Fall Out Rate in Children?
November 25, 2020 updated by: Manchester University NHS Foundation Trust
A Prospective Study to Assess Whether the "Tookie Vest for Oncology" Reduces Central Line Fall Out Rate in the Paediatric Oncology Population
The objective of the trial is to assess whether the TOOKIE vest is an effective intervention in reducing line fall out.
All oncology patients with a tunneled central line will be approached to participate in this study.
Following informed consent they will be issued with a TOOKIE vest.
Study Overview
Detailed Description
All oncology patients with a tunneled central line will be approached to participate in this study.
Following informed consent they will be issued with a TOOKIE vest.
Lines will be studied for the duration they are in situ.
This will vary depending on the underlying diagnosis and treatment regime.
One hundred central line insertions for oncology patients will be prospectively identified and be given the "TOOKIE Vest" to wear.
Data will be collated for each group regarding age, gender, diagnosis, type of central access inserted, duration of line, reason for removal, in cases of infection the infected organism will be documented, date of each fall out.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Manchester, United Kingdom, M13 9WL
- Manchester University NHS Foundation Trust
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second to 16 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any child receiving treatment for malignancy at Royal Manchester Children's Hospital
- Patients with a tunnelled central line inserted for treatment of their malignancy
Exclusion Criteria:
• Any child having a portacath inserted as their mode of central access
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Tookie vest
Participant issued with Tookie vest
|
Tookie Vest
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Central line fall out rate
Time Frame: approximately 1 year
|
approximately 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ross Craigie, Manchester University NHS Foundation Trust
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2019
Primary Completion (Actual)
September 6, 2020
Study Completion (Actual)
September 6, 2020
Study Registration Dates
First Submitted
March 16, 2020
First Submitted That Met QC Criteria
March 26, 2020
First Posted (Actual)
March 27, 2020
Study Record Updates
Last Update Posted (Actual)
November 27, 2020
Last Update Submitted That Met QC Criteria
November 25, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R04675
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Cancer
-
Australian & New Zealand Children's Haematology...Medical Research Future Fund; Minderoo Foundation; Children's Cancer Institute...RecruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
University of Colorado, DenverRecruitingCancer | Childhood CancerUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
Sydney Children's Hospitals NetworkGerman Cancer Research Center; Australian & New Zealand Children's Haematology... and other collaboratorsActive, not recruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
Wake Forest University Health SciencesTerminated
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
-
Pernille BidstrupOdense University Hospital; Aarhus University Hospital; Aarhus University Hospital... and other collaboratorsCompleted
-
Emory UniversityNational Cancer Institute (NCI)Recruiting
-
Children's Cancer Group, ChinaShanghai Children's Medical Center; Shanghai Municipal Center for Disease Prevention...Recruiting
-
St. Jude Children's Research HospitalRecruiting
Clinical Trials on Tookie Vest
-
VA Office of Research and DevelopmentUnited States Military AcademyCompleted
-
VA Office of Research and DevelopmentNot yet recruitingSpinal Cord InjuriesUnited States
-
The Cleveland ClinicCompleted
-
Johns Hopkins UniversityCenters for Medicare and Medicaid Services; Hill-RomCompletedEmphysema | COPD | Chronic BronchitisUnited States
-
Hill-RomCompletedAsthma | Bronchial Asthma | Status AsthmaticusUnited States
-
ReShape LifesciencesUnknown
-
University Hospital, LinkoepingCompletedCardiovascular Risk Factors | Basal Metabolic RateSweden
-
Cardiocentro TicinoRecruitingCoronary Artery DiseaseGermany, Austria, Switzerland, Italy, Spain
-
Vascular Graft Solutions Ltd.CompletedCoronary Artery Bypass SurgeryGermany, United Kingdom
-
Wake Forest University Health SciencesMedifast, Inc.CompletedObesity | OsteoarthritisUnited States